Granite FO »

Vertex Pharmaceuticals Incorporated shares owned by Granite FO

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Granite FO from 13F filings

Historical chart of Granite FO investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Granite FO consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Granite FO

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1k 8 391.63
2025-06-30 $3.6k 8 445.25
2025-03-31 $3.9k 8 484.88
2024-12-31 $3.2k 8 402.75
2024-09-30 $3.7k 8 465.13
2024-03-31 $3.9k 8 489.75

More positions owned by Granite FO

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Vanguard Whitehall Fds High Div Yld (VYM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Micron Technology (MU)
Golub Capital BDC (GBDC)
Blue Owl Capital Com Cl A (OWL)
Ishares Tr Select Divid Etf (DVY)
Ishares Tr Core S&p Scp Etf (IJR)
Ares Capital Corporation (ARCC)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)

View all positions for Granite FO

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated